Bioequivalence Recommendations for Specific Pro­ducts [Regulatives / Guidelines]

posted by cr.maroj – UK, 2013-09-19 13:00 (4254 d 07:28 ago) – Posting: # 11522
Views: 33,955

Hi there,

Could someone please help me with this. Do we get Bioequivalence Recommendations for Specific Products on EMA site, the way they are available on FDA site. (http://www.fda.gov/drugs/guidancecomplianceregulatoryinformation/guidances/ucm075207.htm)

My requirement is, per FDA recommendations for Spironolactone, analytes to be measured for showing BE is just the parent compound. But as we are planning for MHRA submission, I am not sure if MHRA insists on metabolites as well.

Literature shows that, Spironolactone is extensively metabolized; it has three known active metabolites: canrenone, 7-thiomethylspironolactone, and 6-hydroxy-7-thiomethylspironolactone.

Your advise on this will be highly appreciated.

Kind regards
CR

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
137 visitors (0 registered, 137 guests [including 4 identified bots]).
Forum time: 20:29 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5